Redefining cancer immunotherapy—optimization, personalization, and new predictive biomarkers: 4th Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, April 27–30, 2015, Ljubljana, Slovenia
Crossref DOI link: https://doi.org/10.1007/s00262-016-1795-8
Published Online: 2016-01-25
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Aptsiauri, Natalia
Jewett, Anahid
Hurwitz, Arthur A.
Shurin, Michael R.
Umansky, Viktor
Text and Data Mining valid from 2016-01-25